Cost Per Test (CPT): Blood Bank Reagent Testing Supplies for Transfusion Services
Army · W40M MRC0 WEST
Materiality: 0.02% of $QDEL revenue (Low) SEC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation W81K00-25-P-A130 in this department, oldest first.
- Jul 17, 2025 · this noticeAward NoticeORTHO-CLINICAL DIAGNOSTICS, INC · $539K
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
What the notice says
Contract action was not awarded competitively. Ortho-Clinical Diagnostics, Inc. is the only vendor to reply to the solicitation posted on SAM.gov. The solicitation was posted to SAM.gov on April 21, 2025 with a due date of May 7, 2025. After receiving no other interest, Amendment 1 was published on May 7, 2025 further extending the due date to May 22, 2025. No other offers were received. Therefore, Ortho-Clinical Diagnostics, Inc. is the only known source who can meet the Government's requirements.
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (W40M MRC0 WEST), same product/service code (PSC) 6550 and NAICS 334516.
Single-winner award sizes (3): middle half $472K to $3.4M, median $543K; range $401K to $6.3M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SYSMEX AMERICA, INC | 2 | $944K | Jul 16, 2025 |
| CEPHEID Sunnyvale CA 94089 USA | 1 | $6.3M | Jul 28, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Jul 28, 2026CEPHEID Sunnyvale CA 94089 USA$6.3MNotice of Award Cepheid leased analyzer and reagentsNo listed company matched (Materiality N/A)
- Jul 16, 2025SYSMEX AMERICA, INC$401KHematology AnalyzerNo listed company matched (Materiality N/A)
- Jun 23, 2025SYSMEX AMERICA, INC$543KCost Per Reportable reagents with analyzer leaseNo listed company matched (Materiality N/A)
Competitive landscape
For the 2 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Army, Dept of (Corps of Engineers) or Army, Dept of (Other) or Natl Guard since 2024 (0 filings)
- 0 of their lobbyists list a past Army, Dept of (Corps of Engineers) or Army, Dept of (Other) or Natl Guard job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.